Indian coronavirus vaccine could be ready by February: Scientists

India: Scientists in India claims that Indian-government backed coronavirus vaccine could be launched to the world in February, which is months earlier than expected.

Scientists in India indicates that their coronavirus vaccine is on the last stage examinations, and it has been proven safe.

A private company named Bharat Biotech is developing COVAXIN with back from government-run Indian Council of Medical Research (ICMR). Earlier, there had been assumptions that the vaccine could be ready by the second quarter of next year.

ICMR Scientist Rajni Kant, who is a member of the COVID-19 task force, stated that the vaccine has shown good efficacy.

“It is anticipated that by the commencement of next year, February or March, something would be possible.”

A launch in February would make COVAXIN the first India-made vaccine to be propelled out.

ICMR Scientist Rajni Kant believes that aid it was up to the health ministry to determine if COVAXIN shots can be given to people even before the third-stage examinations are completed.

India has the second-largest number of coronavirus cases, behind the United States of America. On Thursday, over 50,201 new coronavirus cases were detected, which takes the total toll to 8.36 million coronaviruses. Over 704 people died on Thursday alone, and the total death toll in India stands at 124,315.

As per Kant, the vaccine has shown positive signs in phase 1 and two trials and also in animal studies which makes it safe, however, it not 100% until the stage 3 trials are completed.

Several leading vaccine candidates are previously in final-stage testing. An innovative vaccine developed by Britain’s AstraZeneca is among the most exceptional ones, and Britain suspects to roll it out in late December or early 2021.

AstraZeneca has contracted several supplies and manufacturing deals with corporations and governments around the globe, including with the Serum Institute of India.